SLGL
Sol-Gel Technologies Ltd.
There isn't enough reported data to score SLGL yet.
SLGL Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Stable | |
| Strong |
SLGL's balance sheet is currently strong, and its cash flow is stable, but its revenue and profitability are weak.
SLGL PE Valuation
SLGL has no meaningful PE right now: it lost money over the past year.
SLGL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect SLGL's losses to grow, with revenue declining.
SLGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$5.64 | -$4.38 |
| Q4 2023 | -$10.10 | -$3.64 |
| Q3 2023 | -$10.90 | -765% |
| Q2 2023 | -$10.30 | -379% |
| Q1 2023 | -$8.16 | -3500% |
| Q4 2022 | -$6.46 | -869% |
| Q3 2022 | $1.64 | +$9.20 |
| Q2 2022 | $3.69 | +$15.49 |
SLGL is still losing money, but far less than before: $5.64 per share over the past year, against $15.60 at its worst in late 2019.
SLGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $591K | -97% |
| Q1 2026 | $108K | -90% |
| Q4 2025 | $696K | +150% |
| Q3 2025 | $400K | -93% |
| Q2 2025 | $17.3M | +218% |
| Q1 2025 | $1M | +121% |
| Q4 2024 | $278K | -38% |
| Q3 2024 | $5.4M | +2417% |
SLGL's revenue has slid since its 2021 peak: $591,000 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -704% | -769 points |
| Q1 2026 | -3569% | -2690 points |
| Q4 2025 | -490% | +1704 points |
| Q3 2025 | -1572% | -1557 points |
| Q2 2025 | 65% | +35 points |
| Q1 2025 | -880% | -2320 points |
| Q4 2024 | -2194% | -984 points |
| Q3 2024 | -15% | +2946 points |
SLGL's operating margin was −704% last quarter, down 769 points from the same quarter a year ago.
SLGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2024 | $0 | $0 |
| Q1 2024 | $0 | $0 |
| Q4 2023 | $0 | $0 |
| Q3 2023 | $0 | $0 |
| Q2 2023 | $0 | $0 |
| Q1 2023 | $0 | $0 |
| Q4 2022 | $0 | +$15.8M |
| Q3 2022 | $0 | $0 |
SLGL's free cash flow was $0 over the past year, against $0 the year before.
SLGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +434K shares |
| 1 year | +17% | +485K shares |
| 3 years | +41% | +958K shares |
| 5 years | +42% | +970K shares |
| Available history | +65% | +1.3M shares |
SLGL has 3M diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
SLGL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -10.4x | Net Cash |
| Q3 2024 | -4.8x | Net Cash |
| Q3 2022 | -1.6x | Net Cash |
| Q2 2022 | -0.5x | Net Cash |
| Q1 2022 | -9.2x | Net Cash |
| Q4 2021 | -4.8x | Net Cash |
SLGL has more cash than debt.
SLGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 15.5 | Oversold |
SLGL's weekly RSI is 39 (neutral) and its Stochastic is 16 (oversold).
SLGL PE vs Healthcare Sector
| Metric | SLGL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SLGL has no meaningful PE right now: it lost money over the past year.
SLGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.2 | 15% below |
| 20 week MA | $72.0 | 22% below |
| 50 week MA | $69.9 | 20% below |
| 100 week MA | $42.6 | 32% above |
| 200 week MA | $30.7 | 83% above |
SLGL has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 83% above its 200-week average.
SLGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $92.3 | $95.0 | +2.9% |
| 2021 | $95.0 | $67.4 | -29% |
| 2022 | $67.4 | $45.0 | -33% |
| 2023 | $45.0 | $11.1 | -75% |
| 2024 | $11.1 | $11.2 | +0.9% |
| 2025 | $11.2 | $41.9 | +274% |
| 2026 YTD | $41.9 | $56.3 | +34% |
SLGL's yearly returns have swung widely, from +274% in 2025 to −75% in 2023. It's up 34% so far in 2026.